Skip to content

A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06691139
Enrollment
80
Registered
2024-11-15
Start date
2022-01-01
Completion date
2024-01-01
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myringoplasty

Brief summary

A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

Detailed description

The aim of this clinical trials is to asses and compare the surgical outcomes of Temporalis fascia graft and periosteal graft in myringoplasty in terms of graft intake and audiological improvement

Interventions

PROCEDUREMyringoplasty using periosteal graft and myringoplasty using Temporalis fascia graft in patients ages from 12 years to 40 years

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia

OTHERMyringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft

Group (A) Myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

PROCEDUREMyringoplasty operation using periosteal graft and myringoplasty using Temporalis fascia graft

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft in age from 12years to 40 years

PROCEDUREGroup (A) myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Myringoplasty operation using Temporalis fascia graft and Myringoplasty using periosteal graft in patients from 12 years to 40 years

Sponsors

Mohamed Soltan Nada
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
12 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

age 12years to 40 years Small to moderate sized perforation . Dry tubotympanic chronic suppurative otitis media For more than 6 weeks .

Exclusion criteria

Active discharge or superimposed otomycosis . Patients with sensorineural hearing loss. Patients with considerable nasal pathology.

Design outcomes

Primary

MeasureTime frameDescription
hearing improvmentfrom January 2022 to January 2024outcome of temporalis fascia graft and periosteal graft for managment tympanic membrane perforation for audiological improvement

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026